t-PA-dependent actiyation of C6 glioma-bound plasminogen: A kinetic study

Fibrinolysis and Proteolysis

Volumn 12, Issue 3, 1998, Pages 137-144

  Pernod, G ^a   Aouffen, M ^a   Polack, B ^a   LeMagueresse Battistoni, B ^b   Benabid, A L ^a   Kolodie L ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BINDING AFFINITY; CELL GROWTH; CELL MIGRATION; ENZYME SUBSTRATE; FIBRINOLYSIS; GLIOBLASTOMA; HUMAN; HUMAN CELL; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 0031727546     PISSN: 13690191     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(98)80295-6     Document Type: Article

References (57)

1. Matrisian L M. The matrix-degrading metalloproteinases. Bioessays 1992; 14: 455-463.
2. Vandenbunder B, Fafeur V, Wernert N, Stéhelin D. Molecular analysis of tumour angiogenesis. M/S 1994; 10: 516-527
3. Vassalli J D, Sappino A P, Belin D. The plasminogen/plasmin system. J Clin Invest 1991; 88: 1067-1072.
4. Kleihues P, Soylemezoglu F, Schäuble B, Scheithauer B W, Burger P C. Histopathology, classification and grading of gliomas. Glia 1995; 15: 211-221.
5. Benabid A L, Remy C, Chauvin C. Experimental models of rat brain tumours by stereotactic injection of C6 glioma and HTC hepatoma cell lines. In: Walker M D, Thomas D G T (eds). Biology of Brain Tumour. Boston: Martinus Nijhoff, 1986: 221-226.
6. Chicoine M R, Silbegeld D L. Invading C6 glioma cells maintaining tumorigenicity. J Neurosurg 1995; 83: 665-671.
7. Nagano N, Sasaki H, Aoyagi M, Hirakawa K. Invasion of experimental rat brain tumour: early morphological changes following microinjection of C6 glioma cells. Acta Neuropathol 1993; 86: 117-125.
8. Bernstein J J, Goldberg W J, Laws E R, Conger D, Morreale V, Wood L R. C6 glioma cell invasion and migration of rat brain after neural homografting: ultrastructure. Neurosurgery 1990; 26: 622-628.
9. Vaithilingam I S, McDonald W, Brown N K, Stroude E, Cook R A, Del Maestro R F. Serum proteolytic activity during the growth of C6 astrocytoma. J Neurosurg 1992; 77: 595-600.
10. Baranova E N, Bajoti K, Remacle A, et al. Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2. FEBS Lett 1997; 405: 157-162.
11. Hoylaerts M, Rijken D C, Lijnen H R, Collen D. Kinetic of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J Biol Chem 1982; 257: 2912-2919.
12. Hembrough T A, Li L, Gonias S L. Cell cytokeratin 8 is the major plasminogen receptor on breast cancer cells and is required for the accelerated activation of cell-associated plasminogen by tissue-type plasminogen activator. J Biol Chem 1996; 271: 25684-25691.
13. Felez J, Miles L A, Fabregas P, Jardi M, Plow E F, Lijnen R H. Characterisation of cellular binding sites and interactive regions within reactants required for enhancement of plasminogen activation by tPA on the surface of leucocytic cells. Thromb Haemost 1996; 76: 577-584.
14. 2-macroglobulin. J Biol Chem 1991; 266: 12329-12336.
15. Andronicos N M, Ranson M, Bognacki J, Bake M S. The human ENO1 gene product (recombinant human α-enolase) displays characteristics required for a plaminogen binding protein. Biochim Biophys Acta 1997; 1337: 27-39.
16. Hajjar K A. Cellular receptors in the regulation of plasmin generation. Thromb Haemost 1995; 74: 294-301.
17. Moser T L, Enghild J J, Pizzo S V, Stack M S. The extracellular matrix proteins laminin and fibronectin contain binding domains for human plasminogen and tissue plasminogen activator. J Biol Chem 1993; 268: 18917-18923.
18. Pernod G, Amalfitano G, Le Magueresse B, Berger F, Polak B, Kolodié L. Retinoids induce t-PA synthesis by C6 glioma cells - Role in tumoral haemorrhagic necrosis. Thromb Haemost 1996; 75: 332-338.
19. Pernod G, Aouffen M, Polak B, Le Magueresse-Battistoni B, Benabid A L, Kolodié L. Synergistic induction of tissue-type plasminogen activator expression by retinoids and cyclic nucleotides in rat C6 glioma cells. Fibrinolysis & Proteolysis 1998; 12: 71-78.
20. Zischler H, Nanda I, Schafer R, Schmid M, Epplen J T. Digoxigenated oligonucleotide probes specific for simple repeats in DNA fingerprinting and hybridisation in situ. Hum Genet 1989; 82: 227-233.
21. Hajjar K A, Hamel N M, Harpel P C, Nachman R L. Binding of tissue plasminogen activator to cultured human endothelial cells. J Clin Invest 1987; 80: 1712-1719.
22. Felez J, Chanquia C J, Fabregas P, Plow E F, Miles L A. Competition between plasminogen and tissue plasminogen activator for cellular binding sites. Blood 1993; 82: 2433-2441.
23. Drapier J C, Tenu J P, Lemaire G, Petit J F. Regulation of plasminogen activator secretion in mouse peritoneal macrophages. I - Role of serum studied by a new spectrophotometric assay for plasminogen activator. Biochimie 1979; 61: 463-471.
24. Borza D B, Morgan W T. Acceleration of plasminogen activation by tissue plasminogen activator on surface-bound histidine-proline-rich glycoprotein. J Biol Chem 1997; 272: 5718-5726.
25. Miwa K, Yamada C, Kono T, Osada H. Retinoic acid enhances plasminogen activation on the cell surface. Thromb Res 1995; 80: 47-56.
26. Ranby M. Studies on the kinetic of plasminogen activation by tissue plasminogen activator. Biochim Biophys Acta 1982; 704: 461-469.
27. Bernstein J J, Laws E R, Levine K V, Wood L R, Tadvalkar G, Goldberg W J. C6 glioma-astrocytoma cell and fetal astrocytes migration into artificial basement membrane: a permissive substrate for neural tumours but not fetal astrocytes. Neurosurgery 1991; 28: 652-658.
28. Berstein JJ, Woodard C A. Glioblastoma cells do not intravasate into blood vessels. Neurosurgery 1995; 36: 124-132.
29. Paganetti P A, Caroni P, Schwab M E. Glioblastoma infiltration into central nervous system tissue in vitro: involvement of a metalloprotease. J Cell Biol 1988; 107: 2281-2291.
30. Vaithilingam I S, Stroude E C, McDonald W, Del Maestro R F. General protease and collagenase (IV) activity in C6 astrocytoma cells, C6 spheroids and implanted C6 spheroids. J Neurooncol 1991; 10: 203-212.
31. Gieze A, Rief M D, Loo M A, Berens M E. Determinants of human astrocytoma migration. Cancer Res 1994; 54: 3897-3904.
32. Hajjar K A, Harpel P C, Jaffe E A, Nachman R L. Binding of plasminogen to cultured human endothelial cells. J Biol Chem 1986; 261: 11656-11662.
33. Duval-Jobe C, Parmely M J. Regulation of plasminogen activation by human U937 promonocytic cells. J Biol Chem 1994; 269: 21353-21357.
34. Redlitz A, Plow E F. Receptors for plasminogen and t-PA: an update. In Lijnen H R, Collen D (eds). Baillière's Clinical Haematology, London: Baillière Tindall 1995: 313-327
35. Hall S W, VandenBerg S R, Gonias S T. Expression of plasminogen receptors on C6 glioma cells. Brain Res 1989; 495: 373-376.
36. Miles L A, Dahlberg C M, Plow E R The cell-binding domains of plasminogen and their function in plasma. J Biol Chem 1988; 263: 11928-11934.
37. Hajjar K A, Jaconiva A T, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 1994; 269: 21191-21197.
38. Hajjar K A, Guevara C A, Lev E, Dowling K, Chacko J. Interaction of the fibrinolytic receptor, annexin II, with the endothelial surface. Essential role of endonexin repeat 2. J Biol Chem 1996; 271: 21652-21659.
39. Paciucci R, Tora M, Diaz V M, Real F X. The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro. Oncogene 1998; 16: 625-633
40. Miles L A, Dahlberg C M, Plescia J, Felez J, Kato K, Plow E F. Role of cell-surfaces lysines in plasminogen binding to cells: identification of α-enolase as a candidate plasminogen receptor. Biochemistry 1991; 30: 1682-1691.
41. Arza B, Felez J, Lopez-Alemany R, Miles L A, Munoz-Canoves P. Identification of an epitope of α-enolase (a candidate plasminogen receptor) by phage dysplay. Thromb Haemost 1997; 78: 1097-1103.
42. Redlitz A, Fowler B J, Plow E F, Miles L A. The role of enolase-related molecule in plasminogen binding to cells. Eur J Biochem 1995; 227: 407-415.
43. Mirshahi S, Lopez-Alemani R, Soria J, et al. Immunolocalization of enolase-related plasminogen receptor (55-60 kDa) in cornea. Fibrinolysis & Proteolysis 1996; 10 (suppl 3): 34 (abstr).
44. Hembrough T A, Vasudevan J, Allietta M M, Glass II W F, Gonias S L. A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes, HepG2 cells and breast carcinoma cell lines. J Cell Sei 1995; 108: 1071-1082.
45. Hembrough T A, Kralovich K R, Li L, Gonias L. Cytokeratin 8 released by breast carcinoma cells in vitro binds plasminogen and tissue-type plasminogen activator and promotes plasminogen activation. Biochem J 1996; 317: 763-769.
46. Stack S, Gonzalez-Gronow M, Pizzo SV. Regulation of plasminogen activation by components of the extracellular matrix. Biochemistry 1990; 29: 4966-4970.
47. Nakajima K, Hamanoue M, Takemoto N, Hattori T, Kato K, Kohsaka S. Plasminogen binds specifically to α-enolase on rat neuronal plasma membranes. J Neurochem 1994; 63: 2048-2057.
48. Parkkinen J, Rauvala H. Interaction of plasminogen and tissue-type plasminogen activator with amphoterin. J Biol Chem 1991; 266: 16730-16735.
49. Machovich R. Kinetic parameters for plasminogen activation by tissue type plasminogen activator. Thromb Haemost 1997; 77: 1041-1042.
50. 1] plasminogen by human tissue plasminogen activator. Biochemistry 1988; 27: 6522-6528.
51. Hall S W, VandenBerg S R, Gonias S L. Plasminogen carbohydrate side chains in receptor binding and enzyme activation: a study of C6 glioma cells and primary cultures of rat hepatocytes. J Cell Biochem 1990, 43: 213-227
52. Nakajima K, Takemoto N, Kohsaka S. Retinoic acid enhances the secretion of plasminogen from rat cultured microglia. FEBS 1992, 314: 167-170.
53. Loscalzo J, Pasche B, Ouimet H, Freedman JE. Platelets and plasminogen activation. Thromb Haemost 1995; 74: 291-293.
54. Borza D B, Morgan W T. Acceleration of plasminogen activation by tissue-type plasminogen activator on surface-bound histidine-proline-rich glycoprotein. J Biol Chem 1997; 272: 5718-5726.
55. Tachias K, Madison E L. Converting tissue-type plasminogen activator into a zymogen. J Biol Chem 1996; 271: 28749-28752.
56. Cesarman G M, Guevara C A, Hajjar K A. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin-mediated enhancement of t-PA-dependent plasminogen activation. J Biol Chem 1994; 269: 21198-21203.
57. Fukao H, Ueshima S, Takaishi T, Okada K, Matsuo O. Enhancement of tissue-type plasminogen activator (t-PA) activity by purified t-PA receptor expressed in human endothelial cells. Biochim Biophys Acta 1997; 111-120.